Basit öğe kaydını göster

Postmenopausal hormone replacement therapy use decreases oxidative protein damage

dc.contributor.authorBilgin, ME
dc.contributor.authorCakatay, U
dc.contributor.authorAkhan, SE
dc.contributor.authorTurfanda, A
dc.contributor.authorSivas, A
dc.contributor.authorTelci, A
dc.date.accessioned2021-03-04T07:40:13Z
dc.date.available2021-03-04T07:40:13Z
dc.date.issued2002
dc.identifier.citationTelci A., Cakatay U., Akhan S., Bilgin M., Turfanda A., Sivas A., "Postmenopausal hormone replacement therapy use decreases oxidative protein damage", GYNECOLOGIC AND OBSTETRIC INVESTIGATION, cilt.54, sa.2, ss.88-93, 2002
dc.identifier.issn0378-7346
dc.identifier.otherav_5f518b7a-4ea4-436f-8c49-86d6fc3c2e0c
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/66595
dc.identifier.urihttps://doi.org/10.1159/000067718
dc.description.abstractObjectives: The aim of this study is to evaluate oxidative protein damage (OPD) by investigating protein carbonyl (PCO) and nitrotyrosine (NT) levels, oxidative stress by total thiol (T-SH), erythrocyte glutathione (GSH) and nitric oxide (NO) levels in women receiving hormone replacement therapy (HRT).
dc.language.isoeng
dc.subjectKadın Hastalıkları ve Doğum
dc.subjectCerrahi Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectKADIN HASTALIKLARI & DOĞUM
dc.titlePostmenopausal hormone replacement therapy use decreases oxidative protein damage
dc.typeMakale
dc.relation.journalGYNECOLOGIC AND OBSTETRIC INVESTIGATION
dc.contributor.department, ,
dc.identifier.volume54
dc.identifier.issue2
dc.identifier.startpage88
dc.identifier.endpage93
dc.contributor.firstauthorID163856


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster